BUSINESS COMBINATION AND DECONSOLIDATION OF SUBSIDIARY (Details Narrative) - USD ($)			1 Months Ended	12 Months Ended
	Jun. 05, 2020	May 14, 2019	Oct. 21, 2020	Dec. 31, 2021	Dec. 31, 2020
Purchase price for the acquisition				$ 14,200,000
Closing Merger Consideration Shares, shares				6,909,091
Contingent Consideration Shares (Clawback Shares), shares				5,988,024
Aggregate amount				$ 20,000,000
Acquisition descriptions				The Company acquired Sera Labs through the issuance of shares of Common Stock of the Company with $1 million of cash consideration to be provided. The preliminary total purchase price was determined based on the following: i) $1 million of the Upfront Payment ii) Company’s closing price ($1.38) on October 2, 2020 for the closing merger consideration shares
Claw back shares		7,128,913
Upfront payment consideration		5,700,000		1
Acheivment shares		3,207,228
Earnout shares		8,018,071
Warrants issue purchase additional shares					4,143,706
Total potential shares to be issued				32,072,283
Upfront payment in cash			$ 1,000,000.0
Working capital			4,000,000.0
Aggregate maximum milestones amount			$ 20,000,000
Potential shares to be issued			5,988,024
Fair value of contingent shares			$ 3,100,000
Cash consideration				$ 1,000,000
Earn out provisions and warrants				32,072,283
Note payable, principal amount				$ 2,000,000
Shares held in escrow				7,128,913
Issuable shares	11,225,299
Returnback shares	140,828
Gross proceed from warrant	$ 1,400,000
Warrant to purchase common stock	7,309,605
Purchase of common stock	708,467
Assigned back shares	310,821
Shares issue to holders	5,612,654
Shares held in escrow	7,128,913
Convertible Note [Member]
Debt instrument converted amount, principal				$ 14,600,000
CHI [Member]
Total purchase price, shares		12,897,115